SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-041805
Filing Date
2024-04-04
Accepted
2024-04-04 16:11:12
Documents
20
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A rgnx-20240404.htm   iXBRL DEF 14A 1229142
2 GRAPHIC img150427478_0.jpg GRAPHIC 19663
3 GRAPHIC img150427478_1.jpg GRAPHIC 30304
4 GRAPHIC img150427478_2.jpg GRAPHIC 26460
5 GRAPHIC img150427478_3.jpg GRAPHIC 380354
6 GRAPHIC img150427478_4.jpg GRAPHIC 189360
7 GRAPHIC img150427478_5.jpg GRAPHIC 176882
8 GRAPHIC img150427478_6.jpg GRAPHIC 210623
9 GRAPHIC img150427478_7.jpg GRAPHIC 471334
10 GRAPHIC img150427478_8.jpg GRAPHIC 201140
  Complete submission text file 0000950170-24-041805.txt   5815586

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgnx-20240404.xsd EX-101.SCH 21808
23 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20240404_htm.xml XML 195313
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37553 | Film No.: 24823253
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)